MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Ixico wins £1.9 million contract to support Huntington's disease study

StockMarketWire.com

Data analytics company Ixico said it had won a £1.9 million contract for a Huntington's disease study with an existing biopharmaceutical sponsor.

Under the contract, the company would provide neuroimaging services to support a clinical trial for Huntington's disease.

This would build on the company's existing relationship with the sponsor with whom they contracted a prior safety and efficacy trial in 2019, the company said.

'This contract was included in management's expectations of performance for the current financial year but adds to the Company's strong order book,' it added.





At 9:28am: (LON:IXI) IXICO plc share price was 0p at 100.5p


Story provided by StockMarketWire.com